Recommended Lazomis QI Resources
Practical guides from the Lazomis QI resource library
- Patient SafetyMedicines Safety: A Systems Approach to Reducing Harm
Polypharmacy is a medicines safety and systems-improvement topic; this guide frames risk reduction across the medicines pathway.
Read article - Clinical AuditHow to Write a Clinical Audit Report: A Practical Guide for UK NHS Teams
Turn polypharmacy audit findings into a structured, governance-ready clinical audit report.
Read article - Quality ImprovementPDSA Cycles: A Practical Guide to Testing Change in Healthcare
Test changes such as medication review prompts, pharmacist review pathways or deprescribing interventions.
Read article - Data and DashboardsUnderstanding and Creating Clinical Audit Dashboards
Interpret and present polypharmacy audit measures and trends using dashboards.
Read article
Audit-specific guidance and standards
National guidance underpinning the polypharmacy review criteria
- NICE NG5 — Medicines optimisation: the safe and effective use of medicines
- NHS England — Structured Medication Reviews and Medicines Optimisation
- NHS Specialist Pharmacy Service — Polypharmacy and deprescribing resources
- STOPP/START criteria version 3 (Age and Ageing, 2023)
- NICE NG56 — Multimorbidity: clinical assessment and management
- Scottish Government — Polypharmacy: Guidance for Prescribing
National guidance informs the audit standard. Local policy, formulary and specialist advice should be followed. This tool supports, but does not replace, clinical judgement.